PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans
© 2017, © The European Society of Cardiology 2017. Background: Proprotein convertase subtilisin kexin type 9 (PCSK9) regulates low-density lipoprotein and very low-density lipoprotein receptor expression in several tissues. Here we evaluated whether PCSK9 may modulate the handling of triglycerides...
| Main Authors: | Baragetti, A., Balzarotti, G., Grigore, L., Pellegatta, F., Guerrini, U., Pisano, G., Fracanzani, A., Fargion, S., Norata, Giuseppe, Catapano, A. |
|---|---|
| Format: | Journal Article |
| Published: |
Sage Publications
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/63473 |
Similar Items
Targeting PCSK9 for hypercholesterolemia
by: Norata, Giuseppe, et al.
Published: (2014)
by: Norata, Giuseppe, et al.
Published: (2014)
Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population
by: Baragetti, A., et al.
Published: (2016)
by: Baragetti, A., et al.
Published: (2016)
PCSK9 inhibition for the treatment of hypercholesterolemia: Promises and emerging challenges
by: Norata, Giuseppe, et al.
Published: (2014)
by: Norata, Giuseppe, et al.
Published: (2014)
Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps
by: Baragetti, A., et al.
Published: (2018)
by: Baragetti, A., et al.
Published: (2018)
PCSK9 inhibitors and dyslipidemia: The clinical evidence
by: Norata, Giuseppe
Published: (2014)
by: Norata, Giuseppe
Published: (2014)
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
by: Casula, M., et al.
Published: (2017)
by: Casula, M., et al.
Published: (2017)
Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure-function relation to therapeutic inhibition
by: Tibolla, G., et al.
Published: (2011)
by: Tibolla, G., et al.
Published: (2011)
Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up
by: Fracanzani, A., et al.
Published: (2016)
by: Fracanzani, A., et al.
Published: (2016)
Epicardial Adipose Tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease
by: Fracanzani, A., et al.
Published: (2016)
by: Fracanzani, A., et al.
Published: (2016)
IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the italian general population
by: Dhyani, A., et al.
Published: (2015)
by: Dhyani, A., et al.
Published: (2015)
Squaring up the health economics of PCSK9 monoclonal antibodies ‘down under’
by: Watts, G., et al.
Published: (2018)
by: Watts, G., et al.
Published: (2018)
MicroRNA 143-145 deficiency impairs vascular function
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population
by: Baragetti, A., et al.
Published: (2015)
by: Baragetti, A., et al.
Published: (2015)
Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions
by: Ruscica, M., et al.
Published: (2017)
by: Ruscica, M., et al.
Published: (2017)
Long pentraxin 3: Experimental and clinical relevance in cardiovascular diseases
by: Bonacina, F., et al.
Published: (2013)
by: Bonacina, F., et al.
Published: (2013)
Lipid Accumulation in Dysferlin-Deficient Muscles
by: Grounds, M., et al.
Published: (2014)
by: Grounds, M., et al.
Published: (2014)
Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)
by: Norata, Giuseppe, et al.
Published: (2016)
Long pentraxin PTX3 as a prognostic marker of cardiovascular mortality in patients with chronic kidney disease
by: Baragetti, A., et al.
Published: (2017)
by: Baragetti, A., et al.
Published: (2017)
Genetically determined telomeres shortening is associated with carotid atherosclerosis progression and increased incidence of cardiovascular events
by: Baragetti, A., et al.
Published: (2016)
by: Baragetti, A., et al.
Published: (2016)
In vivo and in vitro effects of phaleria macrocarpa (scheff.) boerl on low density lipoprotein and pcsk9 expression
by: Chong, Soo Ching
Published: (2011)
by: Chong, Soo Ching
Published: (2011)
-374 T/A RAGE Polymorphism Is Associated with Chronic Kidney Disease Progression in Subjects Affected by Nephrocardiovascular Disease
by: Baragetti, I., et al.
Published: (2013)
by: Baragetti, I., et al.
Published: (2013)
High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease
by: Baragetti, A., et al.
Published: (2013)
by: Baragetti, A., et al.
Published: (2013)
MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice
by: Sala, F., et al.
Published: (2014)
by: Sala, F., et al.
Published: (2014)
Gene silencing approaches for the management of dyslipidaemia
by: Norata, Giuseppe, et al.
Published: (2013)
by: Norata, Giuseppe, et al.
Published: (2013)
Statins and skeletal muscles toxicity: From clinical trials to everyday practice
by: Norata, Giuseppe, et al.
Published: (2014)
by: Norata, Giuseppe, et al.
Published: (2014)
Phaleria macrocarpa (Scheff.) Boerl fruit aqueous extract enhances LDL receptor and PCSK9 expression in vivo and in vitro.
by: Chong, Soo Ching, et al.
Published: (2011)
by: Chong, Soo Ching, et al.
Published: (2011)
Recurrent ectopic pregnancy score as a predictor to fertility outcome following tubal ectopic pregnancy
by: Mohd Nor, Nurul Yaqin
Published: (2018)
by: Mohd Nor, Nurul Yaqin
Published: (2018)
Leonurine: A new comer in the natural compounds affecting atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)
by: Norata, Giuseppe, et al.
Published: (2014)
HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
Cervical Ectopic Pregnancy: A Management Dilemma.
by: Shafiee MN,, et al.
Published: (2012)
by: Shafiee MN,, et al.
Published: (2012)
Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient mice
by: Pulakazhi Venu, V., et al.
Published: (2015)
by: Pulakazhi Venu, V., et al.
Published: (2015)
Prevalence of classical CD14++/CD16 - But not of intermediate CD14++/CD16 + monocytes in hypoalphalipoproteinemia
by: Sala, F., et al.
Published: (2013)
by: Sala, F., et al.
Published: (2013)
A case report of ectopic fibroid: Vaginal leiomyoma
by: Che Hasnura CH,, et al.
Published: (2011)
by: Che Hasnura CH,, et al.
Published: (2011)
Association Of Single Nucleotide Polymorphisms (Snp) In Pcsk9 Gene With Lipid Analysis Among Iban And Bidayuh Ethnic Groups In Sarawak Population.
by: H. H., Hood, et al.
Published: (2015)
by: H. H., Hood, et al.
Published: (2015)
HDL: To treat or not to treat?
by: Pirillo, A., et al.
Published: (2014)
by: Pirillo, A., et al.
Published: (2014)
The CD1d-natural killer T cell axis in atherosclerosis
by: Bondarenko, S., et al.
Published: (2014)
by: Bondarenko, S., et al.
Published: (2014)
Serum progesterone level in predicting ectopic pregnancy.
by: Shahril AZ,, et al.
Published: (2013)
by: Shahril AZ,, et al.
Published: (2013)
High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
Similar Items
-
Targeting PCSK9 for hypercholesterolemia
by: Norata, Giuseppe, et al.
Published: (2014) -
Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population
by: Baragetti, A., et al.
Published: (2016) -
PCSK9 inhibition for the treatment of hypercholesterolemia: Promises and emerging challenges
by: Norata, Giuseppe, et al.
Published: (2014) -
Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps
by: Baragetti, A., et al.
Published: (2018) -
PCSK9 inhibitors and dyslipidemia: The clinical evidence
by: Norata, Giuseppe
Published: (2014)